Valuation Abbisko Cayman Limited

Equities

Market Closed - Hong Kong S.E. Other stock markets 08:08:20 12/03/2026 GMT			5-day change	1st Jan Change
12.40 ^HKD	-2.52%		+12.52%	-4.69%

03-11	Abbisko Drug Receives Rare Pediatric Designation in U.S.	MT
03-11	Abbisko Cayman says US FDA grants rare pediatric disease designation for FGFR2/3 inhibitor ABSK061	RE

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027
Capitalization ¹	5,209	1,993	2,146	2,703	7,317	7,317	-
Change	-	-61.74%	7.72%	25.92%	170.71%	0%	-
Enterprise Value (EV) ¹	2,717	-220.6	175	767.9	5,455	6,012	5,968
Change	-	-108.12%	179.31%	338.89%	610.39%	10.21%	-0.74%
P/E ratio	-0.96x	-3.55x	-4.94x	108x	130x	-161x	-97x
PBR	2.05x	0.75x	1.08x	1.4x	3.43x	3.85x	3.05x
PEG	-	0x	0.3x	-1x	1x	1x	-1.5x
Capitalization / Revenue	230x	-	113x	5.36x	12.8x	31.1x	12.4x
EV / Revenue	120x	-	9.18x	1.52x	8.54x	25.6x	10.1x
EV / EBITDA	-8.59x	0.46x	-0.36x	388x	51.4x	-17.5x	-84.2x
EV / EBIT	-8.28x	0.44x	-0.34x	-35.6x	55.2x	-17.2x	-84.7x
EV / FCF	-15.2x	0.61x	-0.39x	-37.8x	-520x	65x	46.6x
FCF Yield	-6.58%	165%	-260%	-2.65%	-0.19%	1.54%	2.14%
Dividend per Share ²	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-
EPS ²	-7.71	-0.8	-0.67	0.04	0.09	-0.0678	-0.1122
Distribution rate	-	-	-	-	-	-	-
Net sales ¹	22.68	-	19.06	504	612.1	235	590.4
EBITDA ¹	-316.2	-481.4	-492.7	1.978	106.2	-343.7	-70.86
EBIT ¹	-328.2	-497.2	-511.1	-21.59	27.9	-350.1	-70.49
Net income ¹	-1,810	-495.6	-431.6	28.3	55.25	-19.19	-30.83
Net Debt ¹	-2,492	-2,213	-1,971	-1,935	-1,862	-1,305	-1,349
Reference price ²	7.41	2.84	3.31	4.32	10.88	10.88	10.88
Nbr of stocks (in thousands)	702,578	701,774	647,858	625,264	672,361	672,361	-
Announcement Date	18/03/22	15/03/23	12/03/24	03/03/25	02/03/26	-	-

¹CNY in Million²CNY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
ABBISKO CAYMAN LIMITED	45.52x	8.83x	53.14x	-.--%	1.09B
ARGENX SE	42.74x	10x	36.07x	0.03%	44.8B
WUXI APPTEC CO., LTD.	15.94x	5.69x	12.52x	1.88%	40.35B
INSMED INCORPORATED	-51.84x	17.45x	-57.65x	-.--%	30.05B
BIONTECH SE	-17.5x	4.48x	-8.41x	-.--%	21.8B
WUXI BIOLOGICS (CAYMAN) INC.	27.64x	5.7x	15.82x	-.--%	19.09B
GENMAB A/S	22.04x	4.19x	13.68x	-.--%	16.72B
AKESO, INC.	-329.09x	27.33x	1504.74x	-.--%	13.53B
SUMMIT THERAPEUTICS INC.	-14.2x	6349.59x	-18.15x	-.--%	12.47B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	-169.65x	41.3x	-164.02x	-.--%	12.1B
Average	-42.84x	647.45x	138.77x	0.19%	21.2B
Weighted average by Cap.	-24.14x	384.55x	89.31x	0.36%